Abiomed (ABMD) Tops Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts ABMD Hot Sheet
Price: $381.02 --0%
Financial Fact:
Funded research and development: 27K
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Funded research and development: 27K
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Abiomed (NASDAQ: ABMD) reported Q2 EPS of $1.03, $0.06 better than the analyst estimate of $0.97. Revenue for the quarter came in at $248.1 million versus the consensus estimate of $247.66 million.
GUIDANCE:
Abiomed sees FY2022 revenue of $1.01-1.03 billion, versus the consensus of $1.04 billion.
For earnings history and earnings-related data on Abiomed (ABMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance
- ScanSource (SCSC) Tops Q4 EPS by 32c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
